| Product Code: ETC9697501 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Ustekinumab Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Ustekinumab Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Ustekinumab Market - Industry Life Cycle |
3.4 Thailand Ustekinumab Market - Porter's Five Forces |
3.5 Thailand Ustekinumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Ustekinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand Ustekinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and other autoimmune diseases in Thailand |
4.2.2 Growing awareness about ustekinumab as an effective treatment option |
4.2.3 Rising healthcare expenditure and improving access to advanced therapies |
4.3 Market Restraints |
4.3.1 High cost associated with ustekinumab treatment |
4.3.2 Limited reimbursement policies for ustekinumab in Thailand |
4.3.3 Competition from other biologic drugs in the market |
5 Thailand Ustekinumab Market Trends |
6 Thailand Ustekinumab Market, By Types |
6.1 Thailand Ustekinumab Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Ustekinumab Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Ustekinumab Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.4 Thailand Ustekinumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2 Thailand Ustekinumab Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Ustekinumab Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 Thailand Ustekinumab Market Revenues & Volume, By Colitis, 2021- 2031F |
6.2.4 Thailand Ustekinumab Market Revenues & Volume, By Lupus Erythematosus, 2021- 2031F |
6.2.5 Thailand Ustekinumab Market Revenues & Volume, By Myositis Multiplex With Palmoplantar Pustulosis, 2021- 2031F |
6.2.6 Thailand Ustekinumab Market Revenues & Volume, By Cirrhosis Of The Liver, 2021- 2031F |
6.2.7 Thailand Ustekinumab Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.8 Thailand Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 Thailand Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
7 Thailand Ustekinumab Market Import-Export Trade Statistics |
7.1 Thailand Ustekinumab Market Export to Major Countries |
7.2 Thailand Ustekinumab Market Imports from Major Countries |
8 Thailand Ustekinumab Market Key Performance Indicators |
8.1 Number of healthcare professionals trained on ustekinumab usage |
8.2 Patient adherence rates to ustekinumab treatment |
8.3 Number of clinical trials or studies supporting the efficacy of ustekinumab in Thailand |
8.4 Percentage of patients switching to ustekinumab from other treatments |
8.5 Average time taken for ustekinumab to receive regulatory approvals for new indications in Thailand |
9 Thailand Ustekinumab Market - Opportunity Assessment |
9.1 Thailand Ustekinumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Ustekinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand Ustekinumab Market - Competitive Landscape |
10.1 Thailand Ustekinumab Market Revenue Share, By Companies, 2024 |
10.2 Thailand Ustekinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here